首页|期刊导航|药物分析学报（英文）|Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma

Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma

Linlin Qu Yannan Liu Jianjun Deng Xiaoxuan Ma Daidi Fan

药物分析学报（英文）2023，Vol.13Issue(5)：463-482,20.

Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma

Linlin Qu ¹Yannan Liu ²Jianjun Deng ²Xiaoxuan Ma ²Daidi Fan²

作者信息

1. Shaanxi Key Laboratory of Degradable Biomedical Materials,School of Chemical Engineering,Northwest University,Xi'an,710069,China||Shaanxi R&D Center of Biomaterials and Fermentation Engineering,School of Chemical Engineering,Northwest University,Xi'an,710069,China||Biotech.& Biomed.Research Institute,Northwest University,Xi'an,710069,China||Xi'an Giant Biotechnology Co.,Ltd.,Xi'an,710076,China
2. Shaanxi Key Laboratory of Degradable Biomedical Materials,School of Chemical Engineering,Northwest University,Xi'an,710069,China||Shaanxi R&D Center of Biomaterials and Fermentation Engineering,School of Chemical Engineering,Northwest University,Xi'an,710069,China||Biotech.& Biomed.Research Institute,Northwest University,Xi'an,710069,China
折叠

摘要

关键词

Hepatocellular carcinoma/Ginsenoside Rk3/Apoptosis/Autophagy/PI3K/AKT pathway

Key words

Hepatocellular carcinoma/Ginsenoside Rk3/Apoptosis/Autophagy/PI3K/AKT pathway

引用本文复制引用

Linlin Qu,Yannan Liu,Jianjun Deng,Xiaoxuan Ma,Daidi Fan..Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma[J].药物分析学报（英文）,2023,13(5):463-482,20.

基金项目

This work was financially supported by the National Key R&D Program of China(Grant No.:2021YFC2101500),the National Nat-ural Science Foundation of China(Grant Nos.:22078264,21978235,22108224,and 21978236),the Natural Science Basic Research Program of Shaanxi,China(Grant Nos.:2023-JC-JQ-17 and 2023-JC-QN-0109),the Xi'an Science and Technology Project,China(Project No.:20191422315KYPT014JC016),and Key Research and Develop-ment Program of Shaanxi,China(Grant No.:2022ZDLSF05-12). （Grant No.:2021YFC2101500）

药物分析学报（英文）

OACSCD

ISSN：2095-1779

访问量2

下载量0

段落导航